Cart
sales@molnova.com
Dehydroaripiprazole
CAS No. 129722-25-4
Dehydroaripiprazole( OPC-14857 | DM-14857 )
Catalog No. M23455 CAS No. 129722-25-4
Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 342 | In Stock |
|
| 100MG | 505 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1079 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydroaripiprazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
-
DescriptionDehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole. Dehydroaripiprazole has antipsychotic activity equivalent to aripiprazole.
-
In Vitro——
-
In Vivo——
-
SynonymsOPC-14857 | DM-14857
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT1A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number129722-25-4
-
Formula Weight446.37
-
Molecular FormulaC23H25Cl2N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (44.81 mM)
-
SMILESO=C1NC2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kirschbaum KM, et al. Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry. 2008;9(3):212-8.
molnova catalog
related products
-
Pergolide mesylate s...
PERGOLIDE MESYLATE is a long-acting dopamine agonist which has been used to treat parkinson disease and hyperprolactinemiabut withdrawn from some markets due to potential for heart valve diseases.
-
SEP-363856 hydrochlo...
SEP-363856 hydrochloride is an agent of orally active and CNS active psychotropic with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects, has the potential to treatment of schizophrenia. SEP-856 (10μM) specifically inhibits α2A, α2B, D2, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7> 50% receptor.
-
RU-24969
A potent, selective agonist of 5-HT1A and 5-HT1B receptors, with preference for 5-HT1B.
